Obstruction of St Jude medical valves in the aortic position: Histology and immunohistochemistry of pannus

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 2, 2003, Pages 401-407

  Teshima, Hideki ^a   Hayashida, Nobuhiko ^b   Yano, Hirohisa ^b   Nishimi, Masaru ^b   Tayama, Eiki ^b   Fukunaga, Shuji ^b   Akashi, Hidetoshi ^b   Kawara, Takemi ^b   Aoyagi, Shigeaki ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 AZAGUANINE; ALPHA ACTIN; BLOOD CLOTTING FACTOR 8; CD34 ANTIGEN; CD68 ANTIGEN; CD68KP1 ANTIGEN; COLLAGEN; COLLAGEN FIBER; DESMIN; EOSIN; EPITHELIAL MEMBRANE ANTIGEN; GELATINASE B; HEMATOXYLIN; INTERSTITIAL COLLAGENASE; STROMELYSIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; AORTA; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ELASTIC TISSUE; ELASTICA VAN GEISON STAIN; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; GROCOTT STAIN; HEART VALVE REPLACEMENT; HEART VENTRICLE SEPTUM; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INTIMA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; PANNUS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS FAILURE; PROSTHETIC VALVE DYSFUNCTION; PROTEIN EXPRESSION; REOPERATION; SAINT JUDE HEART VALVE PROSTHESIS; STAIN; THROMBUS; TISSUE REPAIR; TISSUE SECTION;

EID: 0041353788     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00702-5     Document Type: Article

References (30)

1. Aoyagi S, Nishimi Y, Tayama E, et al. Obstruction of St. Jude Medical valves in the aortic position: a consideration for pathogenic mechanism of prosthetic valve obstruction. J Cardiovasc Surg. 2002;10:339-44.
2. Schoen FJ. General pathologic considerations. In: Schoen FJ, editor. Interventional and surgical cardiovascular pathology: clinical corrections and basic principles. Philadelphia: Saunders; 1989. p. 1-58.
3. Vitale N, Renzulli A, Agozzino L, et al. Obstruction of mechanical mitral prostheses: analysis of pathological findings. Ann Thorac Surg. 1997;63:1101-6.
4. Barbetseas J, Nagueh SF, Pitsavos C, Toutouzas PK, Quinones MA, Zoghbi WA. Differentiating thrombus from pannus formation in obstructed mechanical prosthetic valves: an evaluation of clinical, transthoracic, and transesophageal echocardiographic parameter. J Am Coll Cardiol. 1998;32:1410-7.
5. Renzulli A, Vitale N, Caruso A, Dialetto G, Schinosa LDLT, Cotrufo M. Thrombolysis for prosthetic valve thrombosis: indications and results. J Heart Valve Dis. 1997;6:212-8.
6. Rizzoli G, Guglielmi C, Toscano G, et al. Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship, and risk. Eur J Cardiothorac Surg. 1999;16:74-80.
7. Ibrahim MF, David TE. Mitral stenosis after mitral valve repair for nonrheumatic mitral regurgitation. Ann Thorac Surg. 2002;73:34-6.
8. Dinarevic S, Redington A, Rigby M, Sheppard MN. Left ventricular pannus causing inflow obstruction late after mitral valve replacement for endocardial fibroelastosis. Pediatr Cardiol. 1996;17:257-9.
9. Dorothy J, Pohlner RPG. Formation of pannus on prosthetic valves in a child with pseoudoxanthoma elasticum. Cardiol Young. 2002;12:183-5.
10. Aoyagi S, Nishimi Y, Kawano H, et al. Obstruction of St. Jude Medical valves in the aortic position: significance of a combination of cineradiography and echocardiography. J Thorac Cardiovasc Surg. 2000;120:142-7.
11. McCune BK, Mullin BR, Flanders KC, Jaffurs WJ, Mullen LT, Sporn MB. Localization of transforming growth factor-β isotypes in lesions of the human breast. Hum Pathol. 1992;23:13-20.
12. Matsushita M, Matsuzaki K, Data M, et al. Down-regulation of TGF-β receptors in human colorectal cancer: implications for cancer development. Br J Cancer. 1999;80:194-205.
13. Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanism. J Am Coll Cardiol. 1992;20:1284-93.
14. Majesky MW, Lindner V, Trwardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest. 1991;88:904-10.
15. Yutani C, Ishibashi-Ueda H, Suzuku T, Kojima A. Histologic evidence of foreign body granulation tissue and de novo lesion in patients with coronary stent restenosis. Cardiology. 1999;92:171-7.
16. Bendeck MP, Conte M, Zhang M, Nili N, Strauss BH, Farwell SM. Doxycycline moderates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol. 2002;160:1089-95.
17. Shi Y, O'Brien JE Jr, Fard A, Zalewski A. Transforming growth factor-β1 expression and myofibroblast formation during arterial repair. Arterioscler Thromb Vasc Biol. 1996;16:1298-305.
18. Kocher O, Gabbinani F, Gabbinani G, et al. Phenotypic features of smooth muscle cells during the evaluation of experimental carotid artery intimal thickening: biochemical and morphologic studies. Lab Invest. 1991;65:459-70.
19. Pulford KAF, Rigney EM, Micklem KJ, et al. KP1: a new monoclonal antibody that detects a monocyte/macrophage associate antigen in routinely processed tissue sections. J Clin Pathol. 1989;42:414-21.
20. Saltis J, Agrotis A, Bobik A. Regulation and interactions of transforming growth factor-β with cardiovascular cells: implications for development and disease. Clin Exp Pharmacol Physiol. 1996;23:193-200.
21. Nikol S, Isner JM, Pickering JG, Kearney M, Leclerc G, Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesion. J Clin Invest. 1992;90:1582-92.
22. White MB, Barbul A. General principles of wound healing. Surg Clin North Am. 1997;77:509-28.
23. Tayama E, Aoyagi S. Asymptomatic prosthetic valve dysfunction. Artif Organs. 2002;26:399-401.
24. Hoch JR, Stark VK, Turnipseed WD. The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression. J Vasc Surg. 1995;22:55-8.
25. Yoneyama T, Ito M, Sugihara K, Ishihara K, Nakabayashi N. Small diameter vascular prosthesis with a nonthrombogenic phospholopid polymer surface: preliminary study of a new concept for functioning in the absence of pseudo- or neointima formation. Artif Organs. 1999;24:23-8.
26. Houel R, Moczar M, Giant M, Loisance D. Pseudointima in flow and outflow conduits of a left ventricular assist system: possible role in clinical outcomes. ASAIO J. 2001;47:275-81.
27. Renzulli A, Luca LD, Verde CR, Galzerano D, Cotrufo M. Acute thrombosis of prosthetic valve: a multivariant analysis of the risk factors for a life-threatening event. Eur J Cardiothoracic Surg. 1992;6:412-21.
28. Yoganathan AP, Corcoran WH, Harrison EC, Carl JR. The Bjork-Shiley aortic prosthesis: flow characteristics, thrombus formation, and tissue overgrowth. Circulation. 1978;58:70-6.
29. Uetsuka Y, Hosoda S, Kasanuki H, et al. Optimal therapeutic range for oral anticoagulants in Japanese patients with prosthetic heart valves: a preliminary report from a single institution using conversion from thrombotest to PT-INR. Heart Vessels. 2000;15:124-8.
30. Becker RC, Eisenberg P, Turpie AGG. Pathobiological features and prevention of thrombotic complications associated with prosthetic heart valves: fundamental principles and the contribution of platelet and thrombin. Am Heart J. 2001;141:1025-37.